Funding This work was supported by the National Natural Science Foundation of China (Grant 81720108030, 81773695, 81803475, 81373371, and 31871810), National Key Research and Development Project of China (2018YFE0208600), China Postdoctoral Science Foundation, the financial support by Key Lab for Drug Delivery & Tissue Regeneration (SS2018004), Jiangsu Provincial Research Center for Medicinal Function Development of New Food Resources, and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions
KPV's targeted modulation of inflammation offers a different profile than blunt-force NSAIDs or steroids
Wu L, Zhou M, Li T, Dong N, Yi L, Zhang Q, et al
It was first isolated from human plasma in 1973